Larimar Therapeutics
0 followers
Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in the Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rar... Read more
Org chart
Carole Ben-Maimon
President & CEO
Carole Ben-Maimon
Collapse
Michael Celano
Chief Financial Officer
Gopi Shankar
Chief Development Officer
Jennifer Johansson
VP, Regulatory, Quality & Legal
Keith E. Lynch, Jr.
VP, CMC Technical Operations
Noreen Scherer
VP, Clinical Operations
Mohamed Hamdani
VP, Statistics & Quantitative Sciences
Keith L.
Vice President, Technical Operations
Adrienne Clements-Egan
Vice President, Bioanalytics & Developability
Michele Walsh
Senior Director Regulatory Affairs
Matt Lynes
Director Technical Operations, Head Of Drug Substance
Scott Straight
Director, Technical Operations, Head Of Drug Product And Supply Chain
Guodong (Gordon) Gu
Associate Director, Bioanalytical Development
Kimberly Minger
Associate Director, Clinical Research
Diana McCarson
Clinical Research Consultant
